Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AngioDynamics, Inc.
Medical device firm reports first quarter sales up 23%
November 6th, 2004
AngioDynamics, Inc., (ANGO) announced financial results for the 13 weeks ended August 28, 2004. Net sales of $13.1 million for the fiscal year 2005 first quarter increased 23% compared with net sales of $10.6 million for the first quarter of fiscal year 2004. This increase was primarily due to strong growth from the company's newest products, along with continued market share gains across the entire product portfolio. VenaCure, AngioDynamics' precision laser system for the treatment of severe varicose veins, continues to sell extremely well under this new brand name. VenaCure procedure kit sales, along with the company's hemodialysis and vascular...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
